Search research articles
Contact Us
Filters
Showing results (51-60 of 96) with videos related to
Page
of 10
Sort By:
Journal of Cancer Research and Clinical Oncology
|
May 18, 2007
Oblimersen and alpha-interferon in metastatic renal cancer: a phase II study of the California Cancer Consortium
Kim Margolin, Timothy W Synold, Primo Lara, et al.
BJC Reports
|
November 8, 2024
Immunogenomics and spatial proteomic mapping highlight distinct neuro-immune architectures in melanoma vs. non-melanoma-derived brain metastasis
Alberto Mendoza-Valderrey, Ethan Dettmann, Douglas Hanes, et al.
Cancers
|
October 27, 2022
Oligometastatic Breast Cancer Patients Treated with High-Dose Chemotherapy and Targeted Radiation: Long-Term Follow-Up of a Phase II Trial
Colton Ladbury, Claire Hao, Christopher Ruel, et al.
Cancers
|
June 2, 2021
Molecular and Clinical Features of Hospital Admissions in Patients with Thoracic Malignancies on Immune Checkpoint Inhibitors
Dan Zhao, Haiqing Li, Isa Mambetsariev, et al.
Nature Communications
|
October 18, 2018
Human breast tumor-infiltrating CD8<sup>+</sup> T cells retain polyfunctionality despite PD-1 expression
Colt A Egelston, Christian Avalos, Travis Y Tu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2007
Phase I trial of BAY 50-4798, an interleukin-2-specific agonist in advanced melanoma and renal cancer
Kim Margolin, Michael B Atkins, Janice P Dutcher, et al.
Cancer Chemotherapy and Pharmacology
|
October 20, 2006
A phase I study of oxaliplatin in combination with gemcitabine: correlation of clinical outcome with gene expression
Stephen Shibata, Warren Chow, Paul Frankel, et al.
Cancer Chemotherapy and Pharmacology
|
January 29, 2010
Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, and carboplatin, in the treatment of recurrent or refractory brain or spinal cord tumors
Robert J Morgan, Timothy Synold, Adam Mamelak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 30, 2011
Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database
Anja Lorch, Caroline Bascoul-Mollevi, Andrew Kramar, et al.
Neuro-Oncology
|
July 7, 2016
Updates in the management of brain metastases
Nils D Arvold, Eudocia Q Lee, Minesh P Mehta, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 96) with videos related to
Sort By:
Page
of 10
Journal of Cancer Research and Clinical Oncology
|
May 18, 2007
Oblimersen and alpha-interferon in metastatic renal cancer: a phase II study of the California Cancer Consortium
Kim Margolin, Timothy W Synold, Primo Lara, et al.
BJC Reports
|
November 8, 2024
Immunogenomics and spatial proteomic mapping highlight distinct neuro-immune architectures in melanoma vs. non-melanoma-derived brain metastasis
Alberto Mendoza-Valderrey, Ethan Dettmann, Douglas Hanes, et al.
Cancers
|
October 27, 2022
Oligometastatic Breast Cancer Patients Treated with High-Dose Chemotherapy and Targeted Radiation: Long-Term Follow-Up of a Phase II Trial
Colton Ladbury, Claire Hao, Christopher Ruel, et al.
Cancers
|
June 2, 2021
Molecular and Clinical Features of Hospital Admissions in Patients with Thoracic Malignancies on Immune Checkpoint Inhibitors
Dan Zhao, Haiqing Li, Isa Mambetsariev, et al.
Nature Communications
|
October 18, 2018
Human breast tumor-infiltrating CD8<sup>+</sup> T cells retain polyfunctionality despite PD-1 expression
Colt A Egelston, Christian Avalos, Travis Y Tu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2007
Phase I trial of BAY 50-4798, an interleukin-2-specific agonist in advanced melanoma and renal cancer
Kim Margolin, Michael B Atkins, Janice P Dutcher, et al.
Cancer Chemotherapy and Pharmacology
|
October 20, 2006
A phase I study of oxaliplatin in combination with gemcitabine: correlation of clinical outcome with gene expression
Stephen Shibata, Warren Chow, Paul Frankel, et al.
Cancer Chemotherapy and Pharmacology
|
January 29, 2010
Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, and carboplatin, in the treatment of recurrent or refractory brain or spinal cord tumors
Robert J Morgan, Timothy Synold, Adam Mamelak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 30, 2011
Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database
Anja Lorch, Caroline Bascoul-Mollevi, Andrew Kramar, et al.
Neuro-Oncology
|
July 7, 2016
Updates in the management of brain metastases
Nils D Arvold, Eudocia Q Lee, Minesh P Mehta, et al.
Page
of 10